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ABSTRACT 
Additive manufacturing (AM) has proven to be an attractive 
alternative manufacturing process compared with subtractive 
manufacturing (SM). Additive manufacturing has many advantages, 
such as mass customisation, less material wastage, and others listed 
in this article. However, the additive manufacturing of certified 
implants does not have the same degree of documentation and 
standardisation as the subtractive manufacturing process. As part 
of this research project, the problem statement is: “In offering 
additive manufacturing as an implant manufacturing solution, the 
complete process (design, manufacturing, and post-processing) had 
to be investigated in order to develop a certified manufacturing 
solution”. 
OPSOMMING 
Toevoegingsvervaardiging is ŉ aantreklike alternatiewe 
vervaardigingsproses teenoor konvensionele vervaardiging. Dit bied 
baie voordele, soos bv. massa-aanpassing, minder materiaal 
vermorsing ensovoorts. Die toevoegingsvervaardiging van 
gesertifiseerde implantate beskik egter nie oor dieselfde mate van 
dokumentasie en standaardisering as die konvensionele proses nie. 
Die volgende probleemstelling is hier aangespreek: “Deur die 
aanbied van toevoegingsvervaardiging as 'n implantaat 
vervaardigingsoplossing, moet die volledige proses (ontwerp, 
vervaardiging en na-vervaardigingsverwerking) ondersoek word om 
'n gesertifiseerde vervaardigingsoplossing te ontwikkel”. 
 
1 INTRODUCTION: 
1.1 Starting as rapid prototyping 
The genesis of additive manufacturing (AM) lies in the concept of rapid prototyping. The first 3D 
printing technology, stereolithography, was invented by Charles Hull in the early 1980s. It was mostly 
applied to the fabrication of visual prototypes to support design and marketing. As 3D technology 
evolved, these prototypes were used as functional prototypes that could be used in fully functional 
mechanical systems. Eliminating the need for tooling and fixturing results in printed prototypes 
being more cost-effective and taking far less time than conventionally manufactured prototypes, 
thus reducing the number of production development steps [1]. 
1.2 Advancement from RP to AM in the biomedical field 
Vandenbroucke and Kruth [16] state that, as a result of the technical improvements of layer 
manufacturing (LM) processes and the possibility of processing different metals (and compounds), 
rapid prototyping (RP) has moved beyond its initial applications into rapid manufacturing (RM). They 
also point out that the progress made could benefit medical and dental applications beyond polymer 
applications for visual (anatomical) models or single-use surgical guides, and support the 
manufacturing of functional implants or prostheses. 
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2 AM MEDICAL DEVELOPMENT 
2.1 Disruption of conventional sectors 
AM technology has disrupted many sectors in the medical industry as more opportunities have arisen 
for change and improvement and as innovations have been introduced. The process used to 
manufacture hearing aids demonstrates the disruption that has resulted from the introduction of AM 
into the industry. Today, 99 per cent of hearing aids that fit into the ear are custom-made using 3D 
printing. As each patient’s ear has a unique shape, 3D printing allows custom-shaped devices to be 
produced efficiently and cost-effectively [17]. 
 
The dentistry sector has transformed its manufacturing processes by embracing 3D printing; it 
rapidly produces crowns, bridges, plaster/stone models, and a range of orthodontic appliances such 
as surgical guides and aligners. Commercial 3D printing of orthodontic braces provides a good 
example of how 3D printing can be used efficiently and profitably to print 50 000 custom-made 
braces daily [2].  
 
Apart from surgical models implants and prostheses, 3D models have been used to aid the 
understanding of biological and biochemical structures. The use of 3D models of molecular 
structures, such as a polypeptide chain, has shown that students are better able to conceptualise 
molecular structures when such 3D models are used [17, 4]. Living human tissue has been fabricated, 
while personalised drug dosing and drug delivery devices with novel drug-release profiles can be 
created using 3D printing [17]. 
2.2 Applicability of direct AM for biomedical applications 
Uklejewski, R., Winiecki, M., Rogala, P. & Mielniczuk, J. [15] report that mass-produced orthopaedic 
end-osseous implants have mainly been produced from wrought or cast bar stock by five- or six-axis 
computerised numerical control (CNC), computer-aided design-driven (CAD) machining, or powder 
metallurgy production methodologies, including hot isostatic pressing and powder injection 
moulding of near-net-shape components. The authors maintain that the traditional process chains 
followed in conventional operations (mainly material removal processes) are failing due to their long 
lead times and material wastage — especially where complex geometries need to be created. In an 
article by Murr, L.E., Quinones, S.A., Gaytan, S.M., Lopez, M.I., Rodela, A., Martinez, E.Y., 
Hernandez, D.H., Martinez, E., Medina, F. & Wicker, R.B. [8], the authors confirm that, through 
material removal processes, often 20 per cent or less of the feedstock is used. However, these 
traditional technologies often fail if the manufacture of an implant component involves a complex 
shape, including thin-walled sections where cutting operations can take a long time owing to 
significant material removal. The authors also maintain that, in many individual cases where patient-
fitted components are required, or if new constructional solutions are under development, low 
effectiveness and the relatively high cost of conventional (removal) machining is disadvantageous. 
2.3 Proven advanced manufacturing and biomedical applications 
In a number of reviewed articles, the authors [3, 8, 16] all agree that the extensive development of 
direct digital manufacturing has recently provided new (promising) perspectives for advanced 
manufacturing technology, including for biomedical applications. The authors agree that recent 
material/compounds and process advances create both new challenges and significant opportunities 
for orthopaedic implant designs [7], cranioplasty implants [5], oral and maxillofacial implants, finger 
joint implants [3], bone substitute implants [6], customised hip and knee implants [12, 8], and dental 
implants [11, 16]. In the report Additive manufacturing: Opportunities and constraints [10], 
published by the Royal Academy of Engineering for a roundtable forum discussion held on 23 May 
2013, biomedical implants were shown to be one of the key developments for the timeline 2013 to 
2018, as shown in Figure 1. 
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Figure 1: AM application timelines [10] 
2.4 Need to certify and standardise the SLM process 
Stahl [14] explains in the report 3D printing: Risks and opportunities that common standards need 
to be developed to ensure that a printed product is identical, independent of the 3D printer used 
(for the same type of technology).  
 
The idea behind this is to ensure the same part integrity where these standards are used anywhere 
in the world. American Society for Testing and Materials and the International Organization for 
Standardization (ISO) have established technical committees for the development of standards for 
AM. Naguy [9], in a presentation entitled Additive manufacturing: Air Force perspective, showed 
the challenges faced in implementing AM. Concerns were raised about the lack of constrained 
process controls and undefined post-processing requirements, among others. The same type of 
certification process described by Naguy [9] is necessary for medical applications. 
2.5 Risk identification  
In the medical device industry, risk management is critical throughout the entire life cycle of a 
device, and it is vital to implement a risk management system successfully to ensure that a safe, 
effective product is manufactured on time and within budget. ISO 14971 is the harmonised standard 
for risk management, which defines the international requirements of risk management systems for 
medical devices. Using ISO 14971 and ISO 13485 as guidelines, it is important to develop a risk 
management procedure, including the relevant flow diagrams, to define how the AM company will 
do risk assessment and management. An overarching process risk assessment was done to determine 
the current risk index — that is, the level of risk multiplied by the probability of occurrence. As 
these patient-specific implants are manufactured in relatively low volumes, the probability of 
occurrence figures will be significantly lower than in a production environment. 
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From the risk assessment it can be seen that the largest risk index relates to the design, 
manufacturing, and post-processing steps. The risk of infection, as part of the surgery and patient 
interface, is also high; but as part of this research project, the implants will be delivered non-sterile 
to the hospital, even though some cleaning and packaging is done. This is to shift the responsibility 
to the hospital, as they need to sterilise all instruments required for surgery. In order to unpack the 
high risks that relate to the design, manufacturing, and post-processing processes, it is important to 
describe and understand the process steps in each of these activities. 
3 DESIGN 
3.1 Overview of design process 
In the case of medical implants, the process starts with scanning the area of the patient where the 
implant will be required with a computerised tomography (CT) or magnetic resonance imaging (MRI) 
scanner. The digital imaging and communications in medicine (DICOM) files from the scanner are 
converted to standard triangulation language (STL) format using dedicated software such as Mimics™ 
from Materialise. The software allows one to alter the grey-scale values from the DICOM images to 
differentiate between soft tissue and bone. In this case, the bone data are exported in STL format 
to show the skeletal features of the patient. The STL file is opened in 3Matic™ software — also from 
Materialise — from where the implant can be designed. Support structures must be added to the 
part to anchor it to the base on which it will be manufactured. This is done through Magics™ 
software. The design file is exported to RP Tools™ from EOS, where the design is sliced into virtual 
slices. The slice file is then exported to the direct metal laser sintering (DMLS) machine where it 
will be manufactured. 
 
A layer of titanium alloy (Ti64) powder is laid down on the build platform inside the EOS M280 DMLS 
machine. The powder layer is the same thickness as that of the slices used in the virtual slicing of 
the part. The first cross-section of the part is scanned with a laser on to the powder. The laser fuses 
the powder particles (also referred to as selective laser melting (SLM)) in an argon atmosphere to 
prevent oxidation. A second layer of powder is laid down on top of the previous one, and the next 
cross-section is scanned. This process is repeated until the part is completed. The build platform 
with the parts attached is removed from the machine, stress-relieved, and the parts are separated 
from the base using a wire cutter. The support structures are removed from the parts, and the 
attachment points are ground smooth. 
 
The design process followed for developing a patient-specific AM implant (author’s own creation): 
 
 Doctor requests a patient-specific device 
 CT/MRI of patient’s affected area is received 
 Where necessary, the patient’s impression is requested 
 Check quality of scan data 
 Doctor submits requirements/inputs 
 Convert CT/MRI conversion with Mimics software 
 Manufacture pre-operative model in nylon 
 Where necessary, surgeon cuts model and prosthodontist makes a wax mock-up of proposed 
implant 
 Wax mock-up is reverse engineered to be used as input geometry for design software  
 Do initial design with 3Matic™ software  
 Send concept to surgeon  
 Do final design  
 Analyse finite element analysis (FEA) on design 
 Design cutting and drill guides  
 Manufacture implant in nylon— fit on pre-operative model and use as sizer in theatre 
 Do design review — design team sign-off 
 Surgeon completes sign-off 
 Manufacture implant in titanium 
 
Figure 2 shows a generic flow diagram for all new product developments. 
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Figure 2: Generic flow diagram for all new product developments (author’s own creation) 
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3.2  Current risks associated with the design process 
The risks in each process step were classified as internal (in-house) and/or external risks. This must 
be seen as an indication of possible risks identified (as a baseline) by the Centre for Rapid 
Prototyping and Manufacturing (CRPM) risk review team, which has used this implant design process 
and SLM process for more than 15 years (The CRPM risk review team comprises the executive 
management, management, the design and quality engineer, and a clinical advisor). It is not an 
exhaustive list, and other users of other technologies could identify additional risks. It is important 
to identify the current risks associated in the design process, and to develop ways to mitigate these 
risks. These risks will be quantified in this section. The risks are split between internal and external 
factors that can influence the outcome. 
 Internal risks 
It is critical when importing the slice data into Mimics to ensure that the anterior of the scan data 
is the patient’s anterior data, and that the scan data is not flipped when shown in the software. 
Inaccurate slice data to STL conversion can result in inaccurate implant designs. Another risk is that 
the implant is under- or over-designed; the former could result in implant failure, while the latter 
could mean discomfort to the patient. Lastly, it is important not to design something that cannot 
be additively manufactured; and here factors such as minimum wall thickness and height-to-width 
ratio of design features must be kept in mind. Table 1 shows some internal risks inherent in the 
design process, and quantifies a factor of risk to the sub-risks. The percentages shown in the tables 
represent the average value obtained from a questionnaire that was completed by experts in the 
field of AM. The composition of the experts was a spread between design, application, quality, and 
risk engineers, and AM centre managers. The risk level was categorised, where one = 0 to 24 per 
cent, two = 25 to 49 per cent, three = 50 to 74 per cent, and four = 75 to 100 per cent.  
Table 1: Identified internal risks in the design process 
Risks % Level Possible ways to mitigate 
Flipped import 
CT slice data 
10 1 Develop standard operating procedure (SOP) 
Slice data to STL 
conversion 
30 2 Software validation 
Over- or under-  
design 
30 2 A team of engineers will conduct the formal design review, which is 
captured in the medical device file. Finite element analysis (FEA) on 
implant to assist design review process 
Design not 
suited for AM 
30 2 Develop design rules 
 External risks 
First, the wrong patient information could be received from the radiologists, resulting in the design 
being based on incorrect patient anatomy. The scan quality must be checked, as slices that are too 
thick can result in inaccurate data extraction. For example, using this data can result in the condyle 
of the mandible not fitting into the glenoid fossa. Another risk is when the doctor’s requirements to 
guide the designer in the appropriate direction are not captured accurately. A summary of some 
external risks is shown in Table 2 below. 
Table 2: Identified external risks for the design process 
Risks % Level Possible ways to mitigate 
Wrong patient information 10 1 Develop medical device file 
Bad quality scan data 40 2 Develop CT scan protocol 
Incorrect input requirements from doctor 50 3 Develop medical device file 
 
It is also important to check the design process against the doctor’s requirements, and to structure 
a design review process. The design can be prototyped and checked against the pre-operative 
planning model, and a metrology comparison can be conducted. To minimise the risk of under- or 
over-designing, a FEA is proposed to check the maximum stress induced in the implant for a specific 
loading.  
 
It is important to conduct a risk assessment that is linked to the development of a checklist of 
compliance with essential requirements for the implant, a pre-operative planning model, and 
drill/cutting guides.  
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The risks were plotted against possible procedures, SOPs, document developments, and validation 
protocols. An example is shown in Table 3 of how these risks could be mitigated. The flipped import 
slice data risk could be addressed in both the product development procedure and the implant design 
SOP. The risk in the process to convert the slice data to STL file could also be addressed in the 
product development procedure, as well as in a full software validation. Even though the software 
is supplied with ISO 13485 certification, the new ISO 13485:2016 version requires the final user to 
validate each in-house designer. The over- and under-design risks could be mitigated as part of the 
product development procedure and the process overview SOP in order to be assessed as part of the 
design review in the medical device file. 
Table 3: Example of risk mitigation process to be followed 
 
4 CONCLUSIONS AND RECOMMENDATIONS 
The aim of this research project was to develop a certification framework focusing on Ti64 titanium 
powder (as the material) and SLM (as the process) for patient-specific implant manufacturing. At 
the start of CRPM’s research into customised Ti64 implants, the surgeons had the authority to 
approve once-off implants. Since the creation of the South African Health Products Regulatory 
Authority (SAHPRA), all medical device distributors/ manufacturers have been expected to register 
with SAHPRA. This implies that CRPM had to develop a certification framework to continue research 
into applications. This was essential to develop a sustainable research and manufacturing centre 
adhering to the regulatory requirements.  
 
One of the objectives was to identify key risks in the SLM process, and to develop work instructions 
and protocols as part of the technical certification process. These instructions will, in turn, assist in 
proving the repeatability and stability of the manufacturing process.  
 
In this project, some 68 risks were identified in the following areas: design, machine setup, powder 
handling, SLM process, part removal, density checks, heat treatment, non-destructive testing, 
destructive testing, surface finishing and coating, cleaning, sterilisation, and packaging.  
 
Of these, 41 were classified as internal risks and 27 as external risks. The purpose of this project 
was to develop a certification framework, and therefore it was more important to explain the 
methodology behind the risk identification and mitigation.  
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The ISO 13485:2016 system is based on continual improvement principles, which means that, where 
new risks arise, the process of addressing these risks will be fast-tracked through the framework 
development. The action plan to mitigate these risks was to develop procedures, SOPs, supportive 
documents and, where needed, full machine and process validation. The procedures, SOPs, 
supportive documents, validations with the highest cumulative risk number, and any risk with a level 
of 3 to 4 were fully analysed as part of the research. Nineteen procedures were identified, and the 
procedure for AM was fully developed.  
  
Thirty-four SOPs were identified in the AM manual as part of the procedure for AM. The 34 SOPs 
were grouped into three categories: general, EOSINT metal AM, and EOSINT polymer AM. The process 
overview SOP was discussed to provide an actual overview of the process chain from prosthesis 
request, through design and manufacturing, until medical device shipment. A proposed process chain 
was introduced as part of the research methodology, as shown in Figure 3 below. 
 
 
Figure 3: The flow diagrams explain the process steps of the prosthesis and prototype 
manufacturing as the first step in developing a procedure 
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Initially, the CRPM was the only entity in Africa to develop ISO procedures for the design and 
manufacturing of customised implants, surgery planning models, and cutting/drilling guides or jigs 
manufactured by AM. During the past year, however, at least two more industrial companies have 
invested about €500 000 to acquire new AM technologies, and they are currently addressing ISO 
certification of AM implants. It is assumed that more will follow. The complete certification process 
of AM has not been published, as a limited number of international service bureaus are working on 
this topic, and the in-house knowledge created is seen as intellectual property and is therefore not 
disclosed. Furthermore, the study could have a significant impact on the use of technology platforms 
at the Central University of Technology (CUT), Stellenbosch University, and the CSIR National Laser 
Centre, or even some local SMMEs. The study fits into the metal additive manufacturing (MAM) 
programme funded by the Department of Science and Technology (DST). The MAM programme forms 
part of a national Collaborative Programme for Additive Manufacturing (CPAM), and one of the 
deliverables is a fully qualified medical implant. The proposed certification framework will be a 
significant contributor in this MAM deliverable.  
 
The CRPM obtained ISO 13485:2012 certification from the international regulating authority TUV 
(Technischer Überwachungsverein) in 2016. The scope of this certification is: 
 
 Design, development, and production of patient-specific custom-made titanium implants using 
3D printing/additive manufacturing. 
 Design, development, and production of patient-specific custom-made preoperative models, 
jigs, and cutting guides in nylon using 3D printing/additive manufacturing. 
 Contract production of titanium implants using 3D printing/additive manufacturing. 
 Contract production of preoperative models, jigs, and cutting guides in nylon using 3D 
printing/additive manufacturing. 
 
The CRPM was successful in migrating to the revised ISO 13485 (2016 version), and the external audit 
was completed by TUV SUD from 22 to 23 March 2018. The International Organization for 
Standardization (ISO) revised the 2012 version, and the ISO 13485:2016 was designed to respond to 
the latest quality management system practices, including changes in expectations. TUV SUD also 
audited all the patient files, as the CRPM had assisted more than 25 patients in the past two years. 
Some of the implants designed and manufactured by CRPM are shown in Table 4. No patient’s 
identity is revealed in the images below. 
Table 4: AM implants designed and manufactured by CRPM (see online version for colour) 
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Recommendations and future work 
The aim of this research project was to develop a certification framework for additive manufactured 
patient-specific implant manufacturing, and to develop similar documentation and standardisation 
as available with the subtractive manufacturing process. The recommendations and future work 
suggested below will assist in fast-tracking this certification process.  
 
Software: Online planning software can be used to discuss a patient’s case remotely with the 
surgeon, as the data or object can be virtually rotated to indicate which area needs to be removed; 
these parameters can then be locked as design input on the medical device file. This online 
communicating tool can provide faster feedback from surgeons on design concepts. 
 
Mobile app for surgeons: 
 
 Post-operative reviews, where the surgeon can give feedback after an operation on possible 
improvements.  
 Meeting minutes translated from voice note to text, and logged into the quality management 
system (QMS).  
 
Software is currently being developed to track powder batch numbers as batches are mixed to form 
recycled powder; this will be an essential input to powder-aging analysis.  
 
Statistical shape modelling techniques can be used to generate swifter patient-specific geometry 
from a database — for example, mandible shapes and sizes. 
 
Hardware: Process monitoring can be further expanded to accommodate recoating monitoring 
(scanning every layer) and melt pool monitoring. Software must be developed to translate all this 
data into a 3D rendering to outline possible areas of concern. Only these areas then need to be 
scanned using CT scanning, and not the complete part, which will result in process cost savings.  
  
Hardware is currently being developed to monitor powder storage, especially with reactive materials 
such as titanium. Monitoring of oxygen content, temperature, and relative humidity are taken in 
real-time. 
 
An automatic surface finishing system must be acquired, as hand-polishing techniques are currently 
used. It is important to note that titanium is not the easiest material to polish, and that sharp edges 
and fine features must be preserved. 
 
Quality Management System:  
 
The systems currently being used are both a manual and an automated system, where files are linked 
to each other and due dates are flagged on procedures and SOPs review dates. The audit planning 
schedules and responsible persons can easily be assigned. It would be advantageous if such an 
automated system could link to an enterprise resource planning (ERP) system to assist with resource 
allocation and product traceability. 
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